323 related articles for article (PubMed ID: 19185004)
21. Role of multidrug resistance 3 deficiency in pediatric and adult liver disease: one gene for three diseases.
Jacquemin E
Semin Liver Dis; 2001 Nov; 21(4):551-62. PubMed ID: 11745043
[TBL] [Abstract][Full Text] [Related]
22. A progressive familial intrahepatic cholestasis type 2 mutation causes an unstable, temperature-sensitive bile salt export pump.
Plass JR; Mol O; Heegsma J; Geuken M; de Bruin J; Elling G; Müller M; Faber KN; Jansen PL
J Hepatol; 2004 Jan; 40(1):24-30. PubMed ID: 14672610
[TBL] [Abstract][Full Text] [Related]
23. Molecular characterization of exons 6, 8 and 9 of ABCB4 gene in children with Progressive Familial Intrahepatic Cholestasis type 3.
Fathy M; Kamal M; Al-Sharkawy M; Al-Karaksy H; Hassan N
Biomarkers; 2016 Nov; 21(7):573-7. PubMed ID: 27075526
[TBL] [Abstract][Full Text] [Related]
24. Combined features of low phospholipid-associated cholelithiasis and progressive familial intrahepatic cholestasis 3.
Poupon R; Barbu V; Chamouard P; Wendum D; Rosmorduc O; Housset C
Liver Int; 2010 Feb; 30(2):327-31. PubMed ID: 19840255
[TBL] [Abstract][Full Text] [Related]
25. ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum.
Reichert MC; Lammert F
Semin Liver Dis; 2018 Nov; 38(4):299-307. PubMed ID: 30357767
[TBL] [Abstract][Full Text] [Related]
26. Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice.
Aronson SJ; Bakker RS; Shi X; Duijst S; Ten Bloemendaal L; de Waart DR; Verheij J; Ronzitti G; Oude Elferink RP; Beuers U; Paulusma CC; Bosma PJ
J Hepatol; 2019 Jul; 71(1):153-162. PubMed ID: 30935993
[TBL] [Abstract][Full Text] [Related]
27. Progressive familial intrahepatic cholestasis.
Srivastava A
J Clin Exp Hepatol; 2014 Mar; 4(1):25-36. PubMed ID: 25755532
[TBL] [Abstract][Full Text] [Related]
28. ABCB4 gene mutations and single-nucleotide polymorphisms in women with intrahepatic cholestasis of pregnancy.
Bacq Y; Gendrot C; Perrotin F; Lefrou L; Chrétien S; Vie-Buret V; Brechot MC; Andres CR
J Med Genet; 2009 Oct; 46(10):711-5. PubMed ID: 19584064
[TBL] [Abstract][Full Text] [Related]
29. Case report: progressive familial intrahepatic cholestasis type 3 with compound heterozygous ABCB4 variants diagnosed 15 years after liver transplantation.
Goubran M; Aderibigbe A; Jacquemin E; Guettier C; Girgis S; Bain V; Mason AL
BMC Med Genet; 2020 Nov; 21(1):238. PubMed ID: 33256620
[TBL] [Abstract][Full Text] [Related]
30. ABCB4 disease: Many faces of one gene deficiency.
Sticova E; Jirsa M
Ann Hepatol; 2020; 19(2):126-133. PubMed ID: 31759867
[TBL] [Abstract][Full Text] [Related]
31. Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4
Wei G; Cao J; Huang P; An P; Badlani D; Vaid KA; Zhao S; Wang DQ; Zhuo J; Yin L; Frassetto A; Markel A; Presnyak V; Gandham S; Hua S; Lukacs C; Finn PF; Giangrande PH; Martini PGV; Popov YV
J Hepatol; 2021 Jun; 74(6):1416-1428. PubMed ID: 33340584
[TBL] [Abstract][Full Text] [Related]
32. Reversal of advanced fibrosis after long-term ursodeoxycholic acid therapy in a patient with residual expression of MDR3.
Frider B; Castillo A; Gordo-Gilart R; Bruno A; Amante M; Alvarez L; Mathet V
Ann Hepatol; 2015; 14(5):745-51. PubMed ID: 26256905
[TBL] [Abstract][Full Text] [Related]
33. 4-phenylbutyrate enhances the cell surface expression and the transport capacity of wild-type and mutated bile salt export pumps.
Hayashi H; Sugiyama Y
Hepatology; 2007 Jun; 45(6):1506-16. PubMed ID: 17538928
[TBL] [Abstract][Full Text] [Related]
34. Cholestatic liver diseases from child to adult: the diversity of MDR3 disease.
Kubitz R; Bode J; Erhardt A; Graf D; Kircheis G; Müller-Stöver I; Reinehr R; Reuter S; Richter J; Sagir A; Schmitt M; Donner M
Z Gastroenterol; 2011 Jun; 49(6):728-36. PubMed ID: 21638239
[TBL] [Abstract][Full Text] [Related]
35. Effect of mdr2 mutation with combined tandem disruption of canalicular glycoprotein transporters by cyclosporine A on bile formation in mice.
Elamiri A; Perwaiz S; Tuchweber B; Yousef IM
Pharmacol Res; 2003 Nov; 48(5):467-72. PubMed ID: 12967592
[TBL] [Abstract][Full Text] [Related]
36. Novel ABCB4 mutation in a Chinese female patient with progressive familial intrahepatic cholestasis type 3: a case report.
Wu Z; Zhang S; Zhang L; Li M
Diagn Pathol; 2020 Apr; 15(1):39. PubMed ID: 32321542
[TBL] [Abstract][Full Text] [Related]
37. Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults.
Stättermayer AF; Halilbasic E; Wrba F; Ferenci P; Trauner M
J Hepatol; 2020 Sep; 73(3):651-663. PubMed ID: 32376413
[TBL] [Abstract][Full Text] [Related]
38. In silico investigation of the impact of synonymous variants in ABCB4 gene on mRNA stability/structure, splicing accuracy and codon usage: Potential contribution to PFIC3 disease.
Khabou B; Siala-Sahnoun O; Gargouri L; Mkaouar-Rebai E; Keskes L; Hachicha M; Fakhfakh F
Comput Biol Chem; 2016 Dec; 65():103-109. PubMed ID: 27788395
[TBL] [Abstract][Full Text] [Related]
39. Successful mutation-specific chaperone therapy with 4-phenylbutyrate in a child with progressive familial intrahepatic cholestasis type 2.
Gonzales E; Grosse B; Cassio D; Davit-Spraul A; Fabre M; Jacquemin E
J Hepatol; 2012 Sep; 57(3):695-8. PubMed ID: 22609309
[TBL] [Abstract][Full Text] [Related]
40. Effect of CFTR correctors on the traffic and the function of intracellularly retained ABCB4 variants.
Ben Saad A; Vauthier V; Tóth Á; Janaszkiewicz A; Durand-Schneider AM; Bruneau A; Delaunay JL; Lapalus M; Mareux E; Garcin I; Gonzales E; Housset C; Aït-Slimane T; Jacquemin E; Di Meo F; Falguières T
Liver Int; 2021 Jun; 41(6):1344-1357. PubMed ID: 33650203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
